Angie You, PhD

CO-FOUNDER

Angie is currently the founder/CEO of Architect Therapeutics. She currently serves on the board of Oric Pharmaceuticals, Attovia Therapeutics and Candid Therapeutics. Angie was most recently CEO of Amunix Pharmaceuticals, which was acquired in 2021 by Sanofi. She served as the CBO at Sierra Oncology (acquired by GSK 2021) and Aragon (acquired by Janssen 2014). She is a scientist by training with a PhD in Biochemistry from Harvard University. She is also a co-founder/board member of ElevAAte, a non-profit focused on advancing East Asian representation at senior levels across the bio and pharma industry.